Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 9,225 | 9,124 | 11,413 | 10,299 | 11,175 |
| Cost of Goods | 1,250 | 2,650 | 2,224 | 2,032 | 2,212 |
| Gross Profit | 7,974 | 6,473 | 9,189 | 8,267 | 8,963 |
| Operating Expenses | 9,756 | 9,402 | 9,702 | 10,146 | 10,467 |
| Operating Income | -1,532 | -2,278 | -289 | -1,847 | -1,292 |
| Interest Expense | 186 | 180 | 149 | 138 | 120 |
| Other Income | 1,897 | 46 | 22 | 626 | 16 |
| Pre-tax Income | 179 | -2,412 | -416 | -1,358 | -1,396 |
| Income Tax | 7 | 62 | -7 | 7 | 7 |
| Net Income Continuous | 172 | -2,474 | -409 | -1,365 | -1,402 |
| Minority Interests | -20 | -19 | -15 | -29 | -17 |
| Net Income | $192 | $-2,441 | $-409 | $-1,336 | $-1,385 |
| EPS Basic Total Ops | 0.01 | -0.17 | -0.03 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | 0.01 | -0.17 | -0.03 | -0.09 | -0.10 |
| EPS Diluted Total Ops | 0.01 | -0.17 | -0.03 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | 0.01 | -0.17 | -0.03 | -0.09 | -0.10 |
| EBITDA(a) | $-276 | $-1,766 | $1,256 | $-228 | $362 |